Abstract
Upon infection of susceptible cells, the RNA genome of the human immunodeficiency virus type 1 (HIV-1) is reverse transcribed into double-stranded DNA, which can be subsequently integrated into the cellular genome. After integration, the viral long terminal repeat (LTR) promoter is present in a nucleosome-bound conformation and is transcriptionally silent in the absence of stimulation. Activation of HIV-I gene expression is concomitant with an acetylation-dependent rearrangement of the nucleosome positioned at the viral transcription start site. Thus, similar to most cellular genes, the transcriptional state of the integrated HIV-I provirus is closely linked to histone acetylation. This enzymatic activity results from the function of histone-specific nuclear acetyltransferase (HAT) enzymes. Efficient viral transcription is strongly dependent on the virally-encoded Tat protein. The mechanism by which Tat increases the rate of transcriptional initiation has been recently demonstrated and involves the interaction of Tat with the transcriptional coactivator p300 and the closely related CREB-binding protein (CBP), having histone acetyltransferase activity
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allfrey, V.G. 1977. Chromatin and chromosome structure. Academic Press, New York.
Arya, S.K., C. Guo, S.F. Josephs, and F. Wong-Staal. 1985. Trans-Activator gene of Human T-Lymphotropic Virus Type III (HTLV-IJI). 229: 69–73.
Avantaggiati, M.L., M. Carbone, Y. Nakatani, B. Howard, and A.S. Levine. 1996. The SV40 large T antigen and adenovirus ElA oncoproteins interact with distinct isoforms of the transcriptional co-activator, p300. EMBO J. 15: 2236–2248.
Benkirane, M., R.F. Chun, H. Xiao, V.V. Ogryzko, B.H. Howard, Y. Nakatani, and K.T. Jeang. 1998. Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J. Biol. Chem. 273: 24898–24905.
Berkhout, B., R.H. Silverman, and K.T. Jeang. 1989. Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 59: 273–282.
Brownell, J.E. and C.D. Allis. 1996. Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. Curr. Opin. Genet. Dev. 6: 176–184.
Calnan, B.J., S. Biancalana, D. Hudson, and A.D. Frankel. 1991. Analysis of argininerich peptides from the HIV-1 Tat protein reveals unusual features of RNA-protein recognition. Genes Dev. 5: 201–210.
Cujec, T.P., H. Okamoto, K. Fujinaga, J. Meyer, H. Chamberlin, D.O. Morgan, and B.M. Peterlin. 1997. The HIV transactivator TAT binds to the CDK-acti,..ting kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. Genes Dev. 11: 2645–2657.
Cullen, B. 1993. Does HIV-1 Tat induce a change in viral initiation rights? Cell 73: 417–420.
d’Adda di Fagagna F., G. Marzio, M.I. Gutierrez, L.K. Kang, A. Falaschi, and M. Giacca. 1995. Molecular and functional interactions of transcription factor USF with the Long Terminal Repeat of Human Immunodeficiency Virus type 1. J. Virol. 69: 2765–2775.
Demarchi, F., P. Bovenzi, D. Di Luca, and M. Giacca. 1996a. Transcriptional activation of human immunodeficiency virus type 1 by herpesvirus infection: an in vivo footprinting study. Intervirology 39: 236–241.
Demarchi, F., F. d’Adda di Fagagna, A. Falaschi, and M. Giacca. 1996b. Activation of transcription factor NF-KB by the Tat protein of human immunodeficiency virus-1. J. Virol. 70: 4427–4437.
Demarchi, F., P. D’Agaro, A. Falaschi, and M. Giacca. 1993. In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1. J. Virol. 67: 7450–7460.
Eckner, R., M.E. Ewen, D. Newsome, M. Gerdes, J.A. De Caprio, J.B. Lawrence, and D.M. Livingston. 1994. Molecular cloning and functional analysis of the adenovirus El A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8: 869–884.
El Kharroubi, A., G. Piras, R. Zensen, and M.A. Martin. 1998. Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter. Mol. Cell. Biol. 18: 2535–2544.
El Kharroubi, A. and E. Verdin. 1994. Protein-DNA interactions within DNase I-hypersensitive sites located downstream of the HIV-1 promoter. J. Biol. Chem. 269: 19916–19924.
Finch, J.T., M. Noll, and R.D. Kornberg. 1975. Electron microscopy of defined lengths of chromatin. Proc.Natl. Acad. Sci. USA 72: 3320–3322.
Ghosh, S., M. Selby, and B. Peterlin. 1993. Synergy between Tat and VP16 in trans-activation of the HIV-1 LTR. J. Mol. Biol. 234: 610–619.
Giebler, H.A., J.E. Loring, K. van Orden, M.A. Colgin, J.E. Garrus, K.W. Escudero, A. Brawweiler, and J.K. Nyborg. 1997. Anchoring of CREB binding protein to the human T-cell leukemia virus type 1 promoter: a molecular mechanism of Tax transactivation. Mol. Cell. Biol. 17: 5156–5164.
Giese, K., J. Cox, and R. Grosschedl. 1992. The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69: 185–195.
Giles, R.H., D.J.M. Peters, and M.H. Breuning. 1998. Conjunction dysfunction: CBP/p300 in human disease. Trends Genet. 14: 178–183.
Gold, M.O., X. Yang, C.H. Herrmann, and A.P. Rice. 1998. PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo J. Virol. 72: 4448–4453.
Gu, W. and R.G. Roeder. 1997. Activation of p53 sequence specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90: 595–606.
Holstege, F.C., P.C. van der Vliet, and H.T. Timmers. 1996. Opening of an RNA polymerase Il promoter occurs in two distinct steps and requires the basal transcription factors IIE and IIH. EMBO J. 15: 1666–1677.
Horikoshi, M., C. Bertuccioli, R. Takada, J. Wang, T. Yamamoto, and R.G. Roeder. 1992. Transcription factor TFIID induces DNA bending upon binding to the TATA element. Proc. Natl. Acad. Sci. USA 89: 1060–1064.
Hottiger, M.O. and G.J. Nabel. 1998. Interaction of human innunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein. J. Virol. 72: 8252–8256.
Ikeda, K., K. Nagano, and K. Kawakami. 1993. Possible implications of Spl-induced bending of DNA on synergistic activation of transcription. Gene 136: 341–343.
Imhof, A., X.J. Yang, V.V. Ogryzko, Y. Nakatani, A.P. Wolffe, and H. Ge. 1997. Acetylation of general transcription factors by histone acetyltransferases. Cuff. Biol. 7: 689–692.
Jeang, K.T., R. Chun, N.H. Lin, A. Gatignol, C.G. Glabe, and H. Fan. 1993. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Spl transcription factor. J. Virol. 67: 6224–6233.
Jones, K.A. 1997. Taking a new TAK on Tat transactivation. Genes Dev. 11: 2593–2599.
Jones, K.A. and B.M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63: 717–743.
Kashanchi, F., G. Piras, M.F. Radonovich, J.F. Duvall, A. Fattaey, C.M. Chiang, R.G. Roeder, and J.N. Brady. 1994. Direct interaction of human TFIID with the HIV-1 transactivator Tat. Nature 367: 295–299.
Koken, S.E., A.E. Greijer, K. Verhoef, J. van Wamel, A.G. Bukrinskaya, and B. Berkhout. 1994. Intracellular analysis of in vitro modified HIV Tat protein. J. Biol. Chem. 269: 8366–8375.
Kuo, M.-H. and C.D. Allis. 1998. Roles of histone acetyltransferases and deacetylases in gene regulation. BioEssays 20: 615–626.
Laughlin, M.A., G.Y. Chang, J.W. Oakes, F. Gonzalez-Scarano, and R.J. Pomerantz. 1995. Sodium butyrate stimulation of HIV-1 gene expression: a novel mechanism of induction independent of NF-kappa B. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 9: 332–339.
Laughlin, M.A., S. Zeichner, D. Kolson, J.C. Alwine, T. Seshamma, R.J. Pomerantz, and F. Gonzalez- Scarano. 1993. Sodium butyrate treatment of cells latently infected with HIV-1 results in the expression of unspliced viral RNA. Virology 196: 496–505.
Luger, K., A.W. Mäder, R.K. Richmond, D.F. Sargent, and T.J. Richmond. 1997. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389: 251–260.
Luger, K. and T.J. Richmond. 1998. DNA binding within the nucleosome core. Curr. Opin. Struct. Biol. 8: 33–40.
Lundblad, J.R., R.P. Kwok, M.E. Laurance, M.L. Harter, and R.H. Goodman. 1995. Adenoviral ElA-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374: 85–88.
Marzio, G., M. Tyagi, M.I. Gutierrez, and M. Giacca. 1998. HIV-1 Tat transactivator recruits p300 and CBP histone acetyl transferases to the viral promoter. Proc. Natl. Acad. Sci. USA 23: 13519–13524.
Maxon, M.E., J.A. Goodrich, and R. Tjian. 1994. Transcription factor IIE binds preferentially to RNA polymerase Ita and recruits TFIIH: a model for promoter clearance. Genes Dev. 8: 515–524.
Muesing, M.A., D.H. Smith, and D.J. Capon. 1987. Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell 48: 691–701.
Owen-Hughes, T. and J.L. Workman. 1994. Experimental analysis of chromatin function in transcriptional control. Critical Review in Eukaryotic Gene Expression 4: 403–441.
Parada, C.A. and R.G. Roeder. 1996. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature 384: 375–378.
Paranjape, S.M., R.T. Kamakaka, and J.T. Kadonaga. 1994. Role of chromatin structure in the regulation of transcrption by RNA polymerase II. Annu. Rev. Biochem. 63: 265–297.
Pomerantz, R.J., D. Trono, M.B. Feinberg, and D. Baltimore. 1990. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell 61: 1271–1276.
Rosen, C.A., J.G. Sodroski, and W.A. Haseltine. 1985. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 41: 813–823.
Steger, D.J. and J.L. Workman. 1997. Stable co-occupancy of transcription factors and histones at the HIV-I enhancer. EMBO J. 16: 2463–2472.
Thomas, J.O. and R.D. Kornberg. 1975. An octamer of histones in chromatin and free in solution. Proc. Natl. Acad. Sci. USA 72: 2626–2630.
Turner, B.M. 1993. Decoding the nucleosome. Cell 75: 5–8.
van Holde, K. and J. Zlatanova. 1996. What determines the folding of the chromatin fiber? Proc. Natl. Acad. Sci. U.S.A 93: 10548–10555.
Van Lint, C., S. Emiliani, M. Ott, and E. Verdin. 1996. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J. 15: 1112–1120.
Verdin, E. 1991. DNase I-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type 1. J. Virol. 65: 6790–6799.
Verdin, E., P. Paras, Jr., and C. Van Lint. 1993. Chromatin disruption in the promoter of human immunodeficiency virús type 1 during transcriptional activation. EMBO J. 12: 3249–3259.
Wei, P., M.E. Garber, S.-M. Fang, W.H. Fisher, and K.A. Jones. 1998. A novel CDK9associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92: 451–462.
Wolffe, A.P. 1994. Transcription: in tune with the histones. Cell 77: 13–16.
Wolffe, A.P. and D. Pruss. 1996. Targeting chromatin disruption: Transcription regulators that acetylate histones. Cell 84: 817–819.
Workman, J.L., I.C.A. Taylor, R.E. Kingston, and R.G. Roeder. 1989. Control of class II gene transcription during in vitro nucleosome assembly. In Methods in Enzymology (ed. P.M. Wasserman and R.D. Kornberg), pp. 419–447. Academic Press, San Diego.
Zhu, Y., T. Pe’ery, J. Peng, Y. Ramanathan, N. Marshall, T. Marshall, B. Amendt, M.B. Mathews, and D.H. Price. 1997. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro Genes Dev. 11: 2622–2632.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Marzio, G., Giacca, M. (1999). Chromatin Control of HIV-1 Gene Expression. In: Bradbury, E.M., Pongor, S. (eds) Structural Biology and Functional Genomics. NATO Science Series, vol 71. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4631-9_13
Download citation
DOI: https://doi.org/10.1007/978-94-011-4631-9_13
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-5782-7
Online ISBN: 978-94-011-4631-9
eBook Packages: Springer Book Archive